HF/CM risks in breast chemotherapy
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
One year after men undergo surgical removal of prostate cancer, they have significant anxiety, which appears to be linked to poor sexual satisfaction and depression.
Flow cytometry has been identified as better for checking for minimal residual disease than two other widely used methods to predict patient survival.
Overweight and obese women with hormone receptor (HR)-positive operable breast cancer have an increased risk of disease recurrence and death.
Persons with more than one glioblastoma tumor upon diagnosis experience significantly worse survival than do patients with a solitary lesion.
A lung cancer risk-prediction model effectively identified individuals who would benefit most from low-dose computed tomography (CT) screening.
Overall survival rates have improved for men with prostate cancer following the introduction of PSA screening, particularly for African Americans.
The magnitude of change in serum prostate-specific antigen (PSA) after 5α-reductase inhibitor therapy may be useful in diagnosing prostate cancer.
Because people who have had multiple bouts of basal cell carcinoma always risk recurrence, the disease can be considered chronic for such patients.
Good endoscopic equipment, endoscopic surgery, and good tissue samples are key to diagnosing and managing esophageal conditions.